
SVNS.L does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for SVNS.L and 80,000+ other tickers.
See exactly how SVNS.L's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SVNS.L and 80,000+ other tickers.
Graft Polymer (UK) Plc, set to become Solvonis Therapeutics plc in January 2025, is dedicated to the research and development of advanced polymer modification technologies and techniques. Its operations span the United Kingdom, Slovenia, and across Europe. The company offers a diverse portfolio of specialized products: GRAFTABOND: A line of graft/block copolymers designed to robustly combine various polymers with materials such as fiberglass, carbon fiber, mineral and natural fillers, and even mixed polymer waste. GRAFTALEN: These are reactive solid super-concentrates engineered to enhance…

Bank of Montreal (TSX:BMO) beat analyst estimates in the third quarter, driven by stronger-than-expected results from its US banking and capital markets...

Shares of Generate Biomedicines Inc (NASDAQ:GENB) jumped more than 20% on Tuesday as investors positioned ahead of the expiration of the company's post-IPO...

11:00am: Consumer confidence falls US consumer confidence and new home sales both came in below expectations in August, adding to signs of caution among...

Dick's Sporting Goods (NYSE:DKS) shares plunged more than 27% on Tuesday after the retailer's second-quarter results missed profit estimates, as weakness at...

Fiserv Inc (NYSE:FI) shares fell more than 3% on Thursday after the payments and financial technology company lowered its 2026 outlook, while second quarter...